RESLIZUMAB prevents the symptoms of
asthma. It is prescribed when other asthma medications have not worked well enough. It works by decreasing inflammation of the airways, making it easier to breathe. Do not use it to treat a sudden asthma attack. It is a
monoclonal antibody. With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.
